Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers. A mini-symposium held at the British Hypertension Society Meeting, September 2005

J Renin Angiotensin Aldosterone Syst. 2006 Jun;7(2):104-21. doi: 10.3317/jraas.2006.008.

Authors

Neil Poulter, Alan D Hughes, Bryan Williams, Adrian J B Brady, Gordon McInnes; British Hypertension Society

PMID: 17083065
DOI: 10.3317/jraas.2006.008

No abstract available

Publication types

Comparative Study
Congress

MeSH terms

Angiotensin II Type 1 Receptor Blockers / pharmacology
Angiotensin II Type 1 Receptor Blockers / therapeutic use*
Angiotensin-Converting Enzyme Inhibitors / pharmacology
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Blood Pressure / drug effects
Diabetes Mellitus / drug therapy
Heart Diseases / complications
Heart Diseases / drug therapy
Humans
Hypertension / complications
Hypertension / drug therapy*
Kidney / drug effects
Renin-Angiotensin System / drug effects*
Societies, Medical
Stroke / prevention & control
United Kingdom

Substances

Angiotensin II Type 1 Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors